Results 101 to 110 of about 9,904 (185)

Lactose-Containing Dry-Powder Inhalers for Patients with Cow's Milk Protein Allergy-The Conundrum; A National Survey of Pediatric Pulmonologists and Allergologists. [PDF]

J Clin Med, 2022
Bar-On O, Levine H, Stafler P, Shmueli E, Jacobi E, Goldberg O, Steuer G, Prais D, Mei-Zahav M.   +8 more
europepmc   +1 more source

Investigation of potential substandard dry powder inhalers on EU and North African markets - evaluation of the delivered and fine particle doses. [PDF]

J Drug Assess, 2022
Zhang Y, Hubert P, Hubert C.
europepmc   +1 more source

Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy

Drug Design, Development and Therapy, 2016
Timothy E Albertson,1–3 Samuel W Bullick,1,3 Michael Schivo,1 Mark E Sutter2,3 1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, 2Department of Emergency Medicine, School of Medicine, UC Davis, Sacramento ...
Albertson TE, Bullick SW, Schivo M, Sutter ME   +3 more
doaj  

Dry Powder Inhalers for Proteins Using Cryo-Milled Electrospun Polyvinyl Alcohol Nanofiber Mats. [PDF]

Molecules, 2022
Ito T, Yamazoe E, Tahara K.
europepmc   +1 more source

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD

International Journal of COPD, 2019
Sohini Ghosh,1 Roy A Pleasants,2 Jill A Ohar,3 James F Donohue,1 M Bradley Drummond1 1Division of Pulmonary Diseases and Critical Medicine, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2Durham VA Medical ...
Ghosh S, Pleasants RA, Ohar JA, Donohue JF, Drummond MB   +4 more
doaj  

State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization. [PDF]

Pharmaceutics, 2022
Groß R, Berkenfeld K, Schulte C, Ebert A, Sule S, Sule A, Lamprecht A.   +6 more
europepmc   +1 more source

Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis

Respiratory Research
Background Chronic obstructive pulmonary disease (COPD) and asthma can be treated with inhaled corticosteroids (ICS) delivered by low climate impact inhalers (dry powder inhalers) or high climate impact inhalers (pressurized metered-dose inhalers ...
Barbara Bonnesen, Josefin Eklöf, Tor Biering-Sørensen, Daniel Modin, Marc Miravitlles, Alexander G. Mathioudakis, Pradeesh Sivapalan, Jens-Ulrik Staehr Jensen   +7 more
doaj   +1 more source

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers. [PDF]

NPJ Prim Care Respir Med, 2022
W H Kocks J, Wouters H, Bosnic-Anticevich S, van Cooten J, Correia de Sousa J, Cvetkovski B, Dekhuijzen R, Dijk L, Dvortsin E, Garcia Pardo M, Gardev A, Gawlik R, van Geer-Postmus I, van der Ham I, Harbers M, de la Hoz A, Janse Y, Kerkhof M, Lavorini F, Maricoto T, Meijer J, Metz B, Price D, Roman-Rodriguez M, Schuttel K, Stoker N, Tsiligianni I, Usmani O, Leving MT.   +28 more
europepmc   +1 more source

Development of an Add-On Device Using 3D Printing for the Enhancement of Drug Administration Efficiency of Dry Powder Inhalers (Accuhaler). [PDF]

Pharmaceutics, 2022
Suwanpitak K, Lim LY, Singh I, Sriamornsak P, Thepsonthi T, Huanbutta K, Sangnim T.   +6 more
europepmc   +1 more source

Efficacy and safety of different inhaler types for asthma and chronic obstructive pulmonary disease. a systematic review and meta-analysis

npj Primary Care Respiratory Medicine
Pressurised metered dose inhalers (pMDIs) contain propellant gases with high global warming potential yet remain a cornerstone of management for asthma and chronic obstructive pulmonary disease (COPD).
Michael J. Loftus, Miranda S. Cumpston, Shannon Barnes, John Blakey, Allan Glanville, Steve McDonald, Loyal Pattuwage, Megan Rees, Rachel Silk, Heath White, Tari Turner, Karin Leder   +11 more
doaj   +1 more source